Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $17.2200 (-0.17%) ($17.2200 - $17.2200) on Mon. Jul. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.43% (three month average) | RSI | 59 | Latest Price | $17.2200(-0.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 2.6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(38%) ARKK(37%) ARKG(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.215% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-7%) IGOV(-4%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.215% (StdDev 4.43%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $16.85(2.2%) | 10 Day Moving Average | $16.29(5.71%) | 20 Day Moving Average | $16.16(6.56%) | To recent high | -0.2% | To recent low | 61.6% | Market Cap | $3.038b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |